DAXDILIMAB

UNII:	CNI3N6QR71
Formula:
Preferred Substance Name:	DAXDILIMAB

2245966-28-1
DAXDILIMAB [INN]
DAXDILIMAB [USAN]
DAXDILIMAB [WHO-DD]
HZN-7734
IMMUNOGLOBULIN G1, ANTI-(HUMAN LEUKOCYTE IG-LIKE RECEPTOR A4) (HUMAN MONOCLONAL VIB7734 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIB7734 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY A MEMBER 4 (CD85 ANTIGEN-LIKE FAMILY MEMBER G, IMMUNOGLOBULIN-LIKE TRANSCRIPT 7))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-452) (HOMO SAPIENS VH (IGHV1-18*01 (99%) (IGHD)-IGHJ2*01 (93%)) (8.8.15) (1-122)-HOMO SAPIENS IGHG1*03) (123-452)) (225-215')-DISULFIDE WITH .LAMBDA. LIGHT CHAIN (1'-216') (HOMO SAPIENS V-LAMBDA (IGLV2-14*01 (98%) IGLJ2*01 (91%))(9.3.10) (1'-107')-HOMO SAPIENS IGLC2*01 (108'-216')), DIMER (231-231'':234-234'')-BISDISULFIDE
MEDI7734
MEDI-7734
VIB7734
VIB-7734

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DAXDILIMAB

Synonyms and Mappings

Resources